AGP Executive Report
Last update: 11 hours agoWHO’s Global Health Role: WHO highlights how it coordinates worldwide action against outbreaks—built on decades of work from smallpox eradication to tracking threats like malaria, HIV/AIDS, polio, TB, and viruses such as SARS‑CoV‑2 and influenza. EFTA–Vietnam Trade (Liechtenstein Included): EFTA ministers say a long-stalled free trade deal with Vietnam is now concluded, paving the way for closer ties with Iceland, Liechtenstein, Norway and Switzerland, with reduced trade barriers and wider coverage including services, investment, IP, procurement and sustainable development. Rett Syndrome Treatment Move: EMA’s CHMP has issued a positive opinion for Acadia’s DAYBU (trofinetide) for neurobehavioral symptoms of Rett syndrome in adults and children aged five and older—next step is an expected European Commission decision. Cancer Care Update: EU approval granted for a KEYTRUDA–Padcev perioperative regimen for certain adults with resectable muscle-invasive bladder cancer who can’t receive cisplatin chemotherapy. Cross-Border Healthcare Basics: A guide explains how healthcare rights work when you’re treated in another European country—what’s covered, when prior authorisation applies, and how costs and claims are handled. Heat & Health Risk: A look back at the 2003 European heatwave links extreme heat to deaths from heat stroke, dehydration and drowning, and asks why air conditioning remains uncommon. Travel Health/Access: EU border delays are expected to worsen as the Entry/Exit System rolls out, with reports of queues and missed flights. Disability Parking Abroad: UK Blue Badge holders are reminded they can use reciprocal parking arrangements in Liechtenstein and other countries.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.